YTE reported $505.92M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 173.33M 14.84M
Agenus AGEN:US $ 53.09M 118K
Agios Pharmaceuticals AGIO:US $ 91.22M 45.26M
Alnylam Pharmaceuticals ALNY:US $ 363.82M 6.04M
Amgen AMGN:US $ 3.77B 854M
Biocryst Pharmaceuticals BCRX:US $ 70.44M 12M
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 244M 29.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Chemocentryx CCXI:US $ 39.68M 5.74M
Clovis Oncology CLVS:US $ 96.06M 39.5M
Cti Biopharma CTIC:US $ 17.07M 2.27M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Exelixis EXEL:US $ 274.84M 29.08M
Gilead Sciences GILD:US $ 3533M 1237M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Idera Pharmaceuticals IDRA:US $ 10.03M 1.99M
Intercept Pharmaceuticals ICPT:US $ 111.01M 12.86M
Macrogenics MGNX:US $ 68.17M 13.31M
Merk MRK:US $ 9066M 5698M
Mirati Therapeutics MRTX:US $ 132.42M 24.38M
Moderna Inc MRNA:US 671M 174.78M
Nektar Therapeutics NKTR:US $ 133.04M 1.14M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Newlink Genetics NLNK:US 8.62M 1.52M
Novartis NVS:US 9.82B 464M
Novartis NOVN:VX 10.28B 107M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 216.09M 852K
Puma Biotechnology PBYI:US $ 78.21M 14.35M
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Sarepta Therapeutics SRPT:US $ 298.8M 17.06M
Seattle Genetics SGEN:US $ 454.4M 18.1M
Ultragenyx Pharmaceutical RARE:US $ 205.96M 18.34M
Vertex Pharmaceuticals VRTX:US $ 836.48M 45.55M
YTE INCY:US $ 505.92M 119.36M